These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17710473)

  • 1. Dose perturbation caused by stents: experiments with a model 90Sr/90Y source.
    Wilczek K; Petelenz B; Strzała A; Marczewska B; Traczyk M; Poloński L
    Cardiovasc Intervent Radiol; 2007; 30(5):981-91. PubMed ID: 17710473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving patient-specific dosimetry for intravascular brachytherapy.
    Li XA; O'Neill M; Suntharalingam M
    Brachytherapy; 2005; 4(4):291-7. PubMed ID: 16344260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of stent on radiation dosimetry in an in-stent restenosis model.
    Fan P; Chiu-Tsao ST; Patel NS; Shih A; Ravi K; Sherman W; Tsao HS; Pisch J; Harrison LB
    Cardiovasc Radiat Med; 2000; 2(1):18-25. PubMed ID: 11229057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry study for beta-radiation treatment of in-stent restenosis.
    Chu CH; Hsieh BT; Chen IJ; Chen WL; Lin UT
    Radiat Prot Dosimetry; 2009 Feb; 134(1):49-54. PubMed ID: 19376885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular brachytherapy and the strontium90 vascular brachytherapy system.
    Reisman M; Gray WA
    J Invasive Cardiol; 2003 Sep; 15(9):520-2; quiz 523. PubMed ID: 12947213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose effects of stents in intravascular brachytherapy for in-stent restenosis: a Monte Carlo calculation.
    Li XA
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):842-8. PubMed ID: 12573772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monte carlo parametric study of stent impact on dose for catheter-based intravascular brachytherapy with 90Sr/90Y.
    Ortego PM; Prieto C; Vano E
    Med Phys; 2004 Jul; 31(7):1964-71. PubMed ID: 15305447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-year results after brachytherapy for diffuse coronary in-stent restenosis: will coronary radiation therapy survive?
    Ruef J; Hofmann M; Störger H; Haase J
    Cardiovasc Revasc Med; 2007; 8(3):170-4. PubMed ID: 17765646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of patients with in-stent restenosis.
    Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
    EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal source position for irradiation of coronary bifurcations in endovascular brachytherapy with catheter based beta or iridium-192 sources.
    Marijnissen JP; Coen VL; van der Giessen WJ; de Pan C; Serruys PW; Levendag PC
    Radiother Oncol; 2004 Apr; 71(1):99-108. PubMed ID: 15066302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta versus gamma for catheter-based intravascular brachytherapy: dosimetric perspectives in the presence of metallic stents and calcified plaques.
    Li XA; Wang R; Yu C; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):1043-9. PubMed ID: 10705028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary revascularisation following intracoronary brachytherapy.
    Sabaté M
    EuroIntervention; 2009 May; 5 Suppl D():D121-6. PubMed ID: 19736060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorbed dose assessment of cardiac and other tissues around the cardiovascular system in brachytherapy with 90Sr/90Y source by Monte Carlo simulation.
    Saghamanesh S; Karimian A; Abdi M
    Radiat Prot Dosimetry; 2011 Sep; 147(1-2):296-9. PubMed ID: 21831866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracoronary radiation for in-stent restenosis in long lesions: too much, too little, too late?
    Gruberg L; Beyar R
    J Invasive Cardiol; 2003 Nov; 15(11):644-5. PubMed ID: 14608137
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of gel dosimetry to measure the 3D dose distribution of a 90Sr/90Y intravascular brachytherapy seed.
    Massillon-Jl G; Minniti R; Mitch MG; Maryanski MJ; Soares CG
    Phys Med Biol; 2009 Mar; 54(6):1661-72. PubMed ID: 19242054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations on radiation source selection and utilization in vascular brachytherapy.
    Crocker I
    J Invasive Cardiol; 2003 Nov; 15(11):664-7; quiz 668. PubMed ID: 14608142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha particle vascular brachytherapy in the treatment of in-stent Restenosis.
    Mehdizadeh A; Fazelzadeh A; Karimi H
    Int J Cardiol; 2009 Aug; 136(2):220-1. PubMed ID: 18625530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary brachytherapy for the treatment of complex in-stent restenosis.
    Cotton JM; Rance K; Patil A; Thomas MR
    Heart; 2005 Feb; 91(2):231-2. PubMed ID: 15657245
    [No Abstract]   [Full Text] [Related]  

  • 19. Patient and personnel dosimetry in endovascular radiotherapy with 90Sr/90Y sources.
    Kalef-Ezra J; Bozios G; Tsekeris P; Michalis L
    Radiat Prot Dosimetry; 2005; 114(4):514-23. PubMed ID: 15941815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of stent on radiation dosimetry in an in-stent restenosis model.
    Fan P; Chiu-Tsao S; Patel NS; Shih A; Ravi K; Sherman W; Tsao H; Pisch J; Harrison LB
    Cardiovasc Radiat Med; 2001 Jan; 2(1):18-25. PubMed ID: 11068251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.